Animantis Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Animantis General Information

Description

Developer of drug discovery platform intended to comprehensively characterize cellular function to guide the future of medicine. The company's cloud-based platform applies computer vision and machine learning techniques in order to maximize meaningful insight from cellular assays, enabling medical practitioners with detailed information that was not accessible before, better-predicting drug efficacy, and improving in vitro assay design.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
+1 (248) 000-0000

Animantis Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Animantis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Jan-2020 00000 Completed Generating Revenue
1. Angel (individual) 22-Jan-2019 00000 00000 Completed Generating Revenue
To view Animantis’s complete valuation and funding history, request access »

Animantis Patents

Animantis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10872410-B2 Methods and apparatus for assessing immune system activity and therapeutic efficacy Active 29-Sep-2016 0000000000 00
EP-3519828-A4 Methods and apparatus for assessing immune system activity and therapeutic efficacy Withdrawn 29-Sep-2016 0000000000 0
EP-3519828-A1 Methods and apparatus for assessing immune system activity and therapeutic efficacy Withdrawn 29-Sep-2016 0000000000
US-20190266723-A1 Methods and apparatus for assessing immune system activity and therapeutic efficacy Granted 29-Sep-2016 G06T7/0012

Animantis Executive Team (3)

Name Title Board Seat Contact Info
Bryan Walker Ph.D Chief Executive Officer & Co-Founder
Ryan Kerwin Co-Founder & Chief Technology Officer
Martin Blanchard Co-Founder, Chief Scientific Officer & Board Member
To view Animantis’s complete executive team members history, request access »

Animantis Board Members (3)

Name Representing Role Since
David Szekeres JD Self Chairman 000 0000
Martin Blanchard Animantis Co-Founder, Chief Scientific Officer & Board Member 000 0000
Thomas Livingston Self Board Member 000 0000
To view Animantis’s complete board members history, request access »

Animantis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
dRx Capital Venture Capital Minority 000 0000 000000 0
To view Animantis’s complete investors history, request access »